Is Apyx Medical Inc (APYX) overvalued? · rev $48.1M
Apyx Medical Inc (APYX) is a medical devices company listed on US.
This page asks whether Apyx Medical Inc (APYX) looks expensive on cached numbers — not a short thesis.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
APYX currently screens at market cap $179.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next APYX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the APYX stock page for the full model, not this heading.
Not investment advice.